Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Questcor Pharmaceuticals Inc QCOR

Healthcare Biotechnology

Recent & Breaking News (NDAQ:QCOR)

BioTime CEO Explains What Could Happen To Stem Cell Research And The Company Under A New Guard In Washington

Benzinga.com  November 22, 2016

Mallinckrodt Set to Join the S&P 500; Rowan to Join S&P MidCap 400; GulfMark Offshore to Join S&P SmallCap 600

PR Newswire August 14, 2014

Mallinckrodt Completes Acquisition Of Questcor Pharmaceuticals

PR Newswire August 14, 2014

Mallinckrodt And Questcor Shareholders Approve Mallinckrodt's Acquisition Of Questcor

PR Newswire August 14, 2014

Institutional Shareholder Services Inc. And Glass Lewis Recommend That Shareholders Of Mallinckrodt And Questcor Vote FOR Mallinckrodt's Acquisition Of Questcor

PR Newswire August 4, 2014

Questcor Reports Record Second Quarter Financial Results

PR Newswire July 24, 2014

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction

PR Newswire July 14, 2014

Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot

PR Newswire June 23, 2014

Questcor Provides Support to Lupus Foundation of America Awareness, Education and Advocacy Efforts

PR Newswire June 3, 2014

Questcor Receives "Recognition of Appreciation" Award from MS Views & News

PR Newswire May 28, 2014

Questcor Enters Into Development Collaboration Agreement Covering Novel Receptor-Selective Melanocortin Peptides

PR Newswire May 14, 2014

Mallinckrodt Pharmaceuticals and Questcor Pharmaceuticals Announce Early Termination of HSR Act Waiting Period

Business Wire May 12, 2014

Clinical Trial Results Indicate Acthar May Significantly Reduce Disease Activity in Patients with Systemic Lupus Erythematosus

PR Newswire May 5, 2014

INVESTOR ALERT - Questcor Pharmaceuticals, Inc.: The Law Offices of Vincent Wong Investigates the Sale of Questcor Pharmaceuticals, Inc. to Mallinckrodt

Business Wire April 30, 2014

QUESTCOR (QCOR) SHAREHOLDER ALERT - The Law firm of Andrews & Springer LLC Announces An Investigation of Questcor Pharmaceuticals, Inc.

PR Newswire April 28, 2014

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Questcor Pharmaceuticals, Inc. of Claims of Breaches of Fiduciary Duty Against Its Board of Directors in Connection With the Sale of the Company to Mallinckrodt -- QCOR

Marketwired April 28, 2014

Questcor Reports First Quarter Financial Results

PR Newswire April 28, 2014

Questcor to Report First Quarter Financial Results on April 28, 2014

PR Newswire April 24, 2014

Who's suing who? Cbeyond (CBEY) pounced on, Questcor (QCOR) buffeted

Gaalen Engen April 23, 2014

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Questcor Pharmaceuticals, Inc. of Claims of Breaches of Fiduciary Duty Against Its Board of Directors in Connection With the Sale of the Company to Mallinckrodt -- QCOR

GlobeNewswire April 23, 2014